Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 40Leukemia, Myelogenous, Chronic, BCR-ABL Positive 32Leukemia 17Leukemia, Myeloid, Chronic-Phase 16Leukemia, Myeloid, Acute 14Breast Neoplasms 12Recurrence 11Leukemia, Lymphocytic, Chronic, B-Cell 10Prostatic Neoplasms 9Neoplasm Metastasis 9Carcinoma, Non-Small-Cell Lung 9Lung Neoplasms 7Blast Crisis 7Pancreatic Neoplasms 6Burkitt Lymphoma 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Neoplasms 5Multiple Myeloma 5Lymphoma, Non-Hodgkin 5Glioma 5Glioblastoma 5Philadelphia Chromosome 4Myelodysplastic Syndromes 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma 4Leukemia, Myeloid, Accelerated Phase 4Gliosarcoma 4Gastrointestinal Stromal Tumors 4Colorectal Neoplasms 4Waldenstrom Macroglobulinemia 3

Interventions

pembrolizumab 1Proton Therapy 1Dasatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hemangiopericytoma × Dasatinib × Clear all
NCT00464620 2018-11-23

Trial of Dasatinib in Advanced Sarcomas

Sarcoma Alliance for Research through Collaboration

Phase 2 Completed
366 enrolled 16 charts
GastrointestinalSarcoma

Chondrosarcoma, Chordoma, Hemangiopericytoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Giant Cell Tumor of Bone, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Gastrointestinal Stromal Tumors, Solitary Fibrous Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡